Senate Finance Committee: Briefing on Prescription Drug Pricing in Annapolis, MD

On January 24, YP-Baltimore chapter leaders Hussain and Minzhi attended a briefing in Annapolis, MD, which was called by the Senate Finance Committee to discuss more about the pricing of prescription drugs.

Key stakeholders were present, including leaders from Pharmaceutical Research and Manufactures Association of America (PhRMA), CareFirst Blue Cross Blue Shield, Pharmaceutical Care Management Association (leader of 12 pharmaceutical benefit managers), research professors from Johns Hopkins, Institute for Clinical and Economic Review, and the Special Assistant from the Office of the Attorney General.  There were four panels with two to four experts. Each expert made a brief presentation related to their perspective on prescription drug pricing and raised discussion on key challenges and recommendations.

At the end of each panel, there was time for questions from senators on the committee. 

Watch the Full Briefing

1.png

Maryland General Assembly – central landmark in Annapolis. Delegates will meet this year from January 11 – April 10, 2017 to debate ~3,500 bills. 

Our coalition introduced 2 bills, known together as the Prescription Drug Affordability Initiative. 

  1. HB 666/SB 437 addresses Prescription Drug Price transparency and Notification for expensive drugs. It is sponsored by Senator Joan Carter Conway (Democrat, District 43, Baltimore City) and House Delegate Eric Bromwell (Democrat, District 8, Baltimore County). 
  2. HB 631/SB 415 is introduced by the Maryland Attorney General Brian Frosh and is against Price-Gouging for Essential Generic drugs

A full hearing of both bills will take place in the Senate Finance committee on February 15 and in the House Health Government Operations committee on February 23.

 

 2.png

Inside the Senate Finance Committee. First gentlemen facing us is Chairman Thomas McLain (Mac) Middleton (Democrat, District 28, Charles County) and next to him is Vice Chairman John Astle (Democrat, District 30, Anne Arundel County). They are leading the briefing, consisting of four panels and 13 speakers in total. 

 

 3.png

Baltimore Chapter Leaders, Minzhi and Hussain (left to right) in front of Maryland General Assembly after the Senate Briefing ended.

 

For more insights into the prescription drug affordability initiatives currently ongoing in Baltimore, MD, check out the following news coverage:
See other pages related to baltimore drug pricing access to medicines

About Hussain Lalani

MD/MPH Candidate at Duke School of Medicine and Johns Hopkins Bloomberg School of Public Health

Be the first to comment
Please check your e-mail for a link to activate your account.
Senate Finance Committee - Jan 24, 2017: Briefing on Prescription Drug Pricing
Senate Finance Committee: Briefing on Prescription Drug Pricing in Annapolis, MD
Home